• Mashup Score: 0
    Program Guide – ASCO Meeting Program Guide - 2 year(s) ago

    AuthorsAmrita Y. KrishnanCity of Hope Comprehensive Cancer Center, Duarte, CAAmrita Y. Krishnan, Alfred L. Garfall, Maria-Victoria Mateos, Niels W.C.J. van de Donk, Hareth Nahi, Jesús F. San-Miguel, Albert Oriol, Laura Rosiñol, Ajai Chari, Manisha Bhutani, Lionel Karlin, Lotfi Benboubker, Lixia Pei, Raluca Verona, Suzette Girgis, Tara Stephenson, Jenna D. Goldberg, Arnob Banerjee, Saad Zafar…

    Source: meetings.asco.org
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HadidiSamer
      HadidiSamer

      #ASCO21 Oral presentation ➡️ https://t.co/d605pTGeTC ⭐️pts (n=156) ⭐️cutoff:2/2021 ⭐️ORR:65%, CR or better:~30%, DOR:NR, AEs👇 https://t.co/EbQO2TfjNX

  • Mashup Score: 0
    NSCLC highlights from ASCO 2021 - 2 year(s) ago

    Heather A. Wakelee, MD, Stanford University, Stanford, CA, discusses non-small cell lung cancer (NSCLC) highlights from the American Society of…

    Source: VJOncology
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJOncology
      VJOncology

      #ASCO22 is fast-approaching! Why not prepare by catching up on some of the highlights from last year’s congress? Here’s @HwakeleeMD of @Stanford giving us a rundown of the highlights in #NSCLC at #ASCO21 https://t.co/1q1Z4AjZH8 @ASCO #LCsm #LungCancer

  • Mashup Score: 0
    2021 ASCO Annual Meeting Plenary Abstracts Shape Practice in 2022—and Beyond - 2 year(s) ago

    As the 2022 ASCO Annual Meeting rapidly approaches, ASCO Daily News looks back on the major research and therapeutic advances reported at last year’s Meeting, including the impact these advances have had on current clinical practice.

    Source: ASCO Daily News
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCO
      ASCO

      Research presented during last year’s Plenary Session heralded important changes to clinical practice. Experts share their perspectives with #ASCODailyNews on how these data shape oncology care. https://t.co/MZwLNWLdsk #cancercare #ASCO21

  • Mashup Score: 2
    Meeting Library | Meeting Library - 2 year(s) ago

    2318 Mill Road, Suite 800, Alexandria, VA 22314 · 571-483-1300 © American Society of Clinical Oncology (ASCO). All Rights Reserved Worldwide.

    Source: meetinglibrary.asco.org
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Personalized, ctDNA analysis to detect minimal residual disease and identify patients at high risk of relapse with multiple myeloma - @bhemato et al. @Phari #ASCO21 Abstract 8029 https://t.co/OyywlExqea #mmsm #mmMRD

  • Mashup Score: 1
    Meeting Library | Meeting Library - 2 year(s) ago

    2318 Mill Road, Suite 800, Alexandria, VA 22314 · 571-483-1300 © American Society of Clinical Oncology (ASCO). All Rights Reserved Worldwide.

    Source: meetinglibrary.asco.org
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      WBMRI vs FDG PET/CT for detection of multiple myeloma & correlation w/ markers of disease burden: Results of the iTIMM trial - Kaiser et al. #ASCO21 Abst 8012 https://t.co/oUeF6cxbTe #mmsm #mmMRD #oncorad

  • Mashup Score: 2
    Meeting Library | Meeting Library - 2 year(s) ago

    2318 Mill Road, Suite 800, Alexandria, VA 22314 · 571-483-1300 © American Society of Clinical Oncology (ASCO). All Rights Reserved Worldwide.

    Source: meetinglibrary.asco.org
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Biomarker tissue journey among patients with untreated metastatic non-small cell lung cancer (mNSCLC) in the U.S. Oncology Network community practices - Robert et al. Abstract 9004 #ASCO21 https://t.co/Trp655kOjb #lcsm #PrecisionMedicine

  • Mashup Score: 1
    Meeting Library | Meeting Library - 2 year(s) ago

    2318 Mill Road, Suite 800, Alexandria, VA 22314 · 571-483-1300 © American Society of Clinical Oncology (ASCO). All Rights Reserved Worldwide.

    Source: meetinglibrary.asco.org
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Myocarditis as a rare, yet serious adverse event associated w/ immune checkpoint inhibitors in patients with NSCLC: Case series from a large community-based cancer center - Hendawi et al @Aurora_Cancer @Syapse #ASCO21 Abs e21047 https://t.co/OFrRxoxrt6 #irAE #ImmunoOnc #CardioOnc

  • Mashup Score: 0
    People with cancer are likely to accept the COVID-19 vaccine, but politics tracks with attitudes: An inspire and COSMO survey. - 2 year(s) ago

    1531 Background: Vaccines are a major step towards control of the COVID-19 pandemic. Estimates from multiple surveys of the general public indicate that 40 to 60% plan to be vaccinated, with some data suggesting that uptake differs by political leanings. The views of people with cancer on COVID-19 vaccination have not been reported. We report survey results of people with cancer, evaluating…

    Source: Journal of Clinical Oncology
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      People w/ Cancer More Likely to Accept #COVID19Vaccine, But Politics Tracks w/ Interest: An Inspire & #COSMOnc Survey - @drdonsdizon Hoffman, Gentile, Tsai, @J2Novack @DrAttai @DrMarkham @l_schapira @davidgrahammd @mtmdphd #ASCO21 Abs 1531 https://t.co/SXFs3ZMvKL #COVID19nCancer https://t.co/U3YbcEMMQM

  • Mashup Score: 0
    Meeting Library | Meeting Library - 2 year(s) ago

    2318 Mill Road, Suite 800, Alexandria, VA 22314 · 571-483-1300 © American Society of Clinical Oncology (ASCO). All Rights Reserved Worldwide.

    Source: meetinglibrary.asco.org
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Genomic markers associated with hyperprogression in patients with lung cancer treated with immune checkpoint inhibitors - Tadesse et al. @Aurora_Cancer #ASCO21 Abs 9105 https://t.co/Ipuygzubfa #PrecisionMedicine #ImmunoOnc https://t.co/4D83SSk684

Load More